• Explore /
  • Poster
  • / Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post-hoc analysis of the randomized, phase III KEYNOTE-240 study.

Landmark analysis of overall survival (OS) by objective response (OR) in previously treated patients (pts) with advanced hepatocellular carcinoma (aHCC): Post-hoc analysis of the randomized, phase III KEYNOTE-240 study.

Abstract Video & Slides Poster

Authors

null

Julien Edeline

Centre Eugène Marquis, Rennes, France

Julien Edeline , Stéphane Cattan , Philippe Merle , Bruno Daniele , Stephen Lam Chan , Thomas Yau , Mohamed Bouattour , Ho Yeong Lim , Yee Chao , Jennifer J. Knox , Sadahisa Ogasawara , Marcelo Garrido , Ann-Lii Cheng , Andrew X. Zhu , Richard S. Finn , Abby B. Siegel , Ahmadur Rahman , Chih-Chin Liu , Masatoshi Kudo

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session: Hepatobiliary Cancer

Track

Hepatobiliary Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT02702401

Citation

J Clin Oncol 39, 2021 (suppl 3; abstr 318)

DOI

10.1200/JCO.2021.39.3_suppl.318

Abstract #

318

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Zhenggang Ren

First Author: Richard S. Finn

First Author: Shukui Qin

First Author: Shukui Qin